Federal health officials are cracking down on a controversial therapy that has been promoted as an alternative for a variety of conditions, including autism, Alzheimer's disease and Parkinson's disease.
The Food and Drug Administration warned eight companies Thursday that their over-the-counter products used for a procedure known as "chelation" are "unapproved drugs and devices" and so are in "violation of federal law."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment